Lidds AB

Quick facts

Phase 1 pipeline

• 2-Hydroxyflutamide · Oncology
  Anti-androgen receptor antagonist

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Lidds AB portfolio CI brief
• Lidds AB pipeline updates RSS